Probiotics in the Reduction of Adverse Effects and Dysbiosis of H. Pylori Eradication

NCT03722433 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Infection

Interventions

DRUG: Vigiis 101-LAB and sequential therapy
DRUG: Placebo and sequential therapy

Sponsor

National Taiwan University Hospital